Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    16782488 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed Randomised Trial of Structured Treatment Interruption of HAART in HIV-Infected Adults in Abidjan (ANRS 1269 TRIVACAN)
Condition: HIV Infections
Interventions: Procedure: Structured Treatment Interruption;   Drug: Zidovudine (ZDV);   Drug: Lamivudine (3TC);   Drug: Efavirenz (EFV);   Drug: Ritonavir (NRV);   Drug: Indinavir (IDV)

Indicates status has not been verified in more than two years